Cboe Global Markets, Inc.

10-QQ3 FY2026PositiveRestructuring
Filed Oct 30
Extended exclusive SPX rights and overseas exits sharpen the derivatives focus; Australia sale gain boosts reported profit.
- Revenue$1.4BYoY +19.0%
- Net income$428.2MYoY +42.4%
8-KPositiveEarningsGuidance raisedImpairment / charge
Filed Oct 30
Record 0DTE activity supported index-options demand; FY2026 organic revenue growth outlook raised to high teens, adjusted expense guidance cut to $830M–$845M.
8-KPositiveGuidance deferred to the callContract / partnership
Filed Sep 29
Exclusive S&P 500 options license extended through 2051; updated royalties expected to have de minimis impact on 2027 net revenue growth.
10-QQ2 FY2026PositiveRestructuring
Filed Jul 31
Options trading growth outpaced costs as planned Australia and Canada sales to TMX sharpen the focus on derivatives and data.
- Revenue$1.4BYoY +22.9%
- Net income$353.1MYoY +50.2%
8-KPositiveEarningsGuidance raisedImpairment / charge
Filed Jul 31
Record Options activity drives growth; FY2026 organic net revenue growth target rises to mid-to-high teens Y/Y.
8-KDebt financing
Filed Jul 28
Restated $400M five-year revolver adds covenant permissions for clearing activities
8-KDebt financing
Filed Jun 26
Cboe Clear Europe extends its €1.2B credit facility through June 25, 2027; Cboe’s guarantee continues.

Coverage: 10-K, 10-Q and 8-K filings filed since Jun 1, 2026.

10-QQ3 FY2026PositiveRestructuring